Predicting Therapeutic Efficacy of Vascular Disrupting Agent CA4P in Rats with Liver Tumors by Hepatobiliary Contrast Agent Mn-DPDP-Enhanced MRI

To evaluate hepatobiliary-specific contrast agent (CA) mangafodipir trisodium (Mn-DPDP)–enhanced magnetic resonance imaging (MRI) for predicting the therapeutic efficacy of the vascular disrupting agent combretastatin A4 phosphate (CA4P) in rats with primary and secondary liver tumors, 36 primary he...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yewei, Guan, Qiu, Kong, Xiangyong, De Keyzer, Frederik, Feng, Yuanbo, Chen, Feng, Yu, Jie, Liu, Jianjun, Song, Shaoli, van Pelt, Jos, Swinnen, Johan, Bormans, Guy, Oyen, Raymond, Wang, Shuncong, Huang, Gang, Ni, Yicheng, Li, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909075/
https://www.ncbi.nlm.nih.gov/pubmed/31810003
http://dx.doi.org/10.1016/j.tranon.2019.09.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909075/
https://www.ncbi.nlm.nih.gov/pubmed/31810003
http://dx.doi.org/10.1016/j.tranon.2019.09.010

Ejemplares similares